GulfBase Live Support
Leave a message and our representative will contact you soon
24/12/2017 06:18 AST
National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a rights issue. The company has received approval from the Capital Market Authority (CMA) for the rights issue and accordingly, 50 million shares will be issued to the existing shareholders at a price of 102 baisas per share.
The board of directors of the company approved a proposal to raise of the company's capital from OMR5 million to OMR10 million.
The CMA approved the rights issue prospectus based on the request of the company's management and in compliance with all the requirements of the issue.
Times of Oman
| Ticker | Price | Volume |
|---|
07/11/2025
In a new achievement that confirms its leadership in adopting the highest sustainability standards, National Bank of Kuwait building won the award of Best Financial Building as part of the GCC Excell
Kuwait Times
07/11/2025
Adnoc Distribution Chief Executive Officer Bader Al Lamki said the company earmarks between $250 million and $300 million annually to support organic growth across the three countries where it operat
Trade Arabia
07/11/2025
IHC, the Abu Dhabi headquartered global investment company focused on building dynamic value networks, on Thursday reaffirmed that it does not intend to pursue the sale of its shareholding in Aldar P
Trade Arabia
07/11/2025
Aramex has resumed parcel and freight deliveries to Syria as of 15 September 2025, officially ending a suspension that lasted more than ten years. The move marks a major step in rebuilding trade rout
Gulfnews
07/11/2025
Parkin Company PJSC, Dubai's largest provider of paid public parking, reported record third-quarter results, with revenues up 43% year-on-year to Dh343.3 million, driven by higher tariffs, network ex
Gulfnews